title: Re: effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
authors.forename: Dean G
authors.initials: DG
authors.lastname: Assimos
mesh_terms: D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D053565:Hypercalciuria / Q000188:drug therapy*; D008297:Male; D053040:Nephrolithiasis / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*
chemical_list: D050071:Bone Density Conservation Agents; D049993:Sodium Chloride Symporter Inhibitors; D019386:Alendronate